EXELIXIS
For Exelixis’ excellent news, please read our latest article, "Exelixis’ (EXEL) Exceptional Financial Results and Corporate Achievements", under Today’s Highlights
NEUROCRINE BIOSCIENCE
Prohost Picked this firm on April 24, 2017, at $51 (see the Prohost Portfolio in the Prohost Letter). Today, Thursday, November 2, NBIX closed on at $72.78 Up $11.85
In its Q3 report, Neurocrine Biosciences (NBIX) announced financial results that beat analysts’ expectations by more than $30 million. The firm generated $60.77 million . . .
This content is for paid subscribers.
Today’s Highlights
November 3, 2017